flipper44- I like to see a mini trial (of course after approval of DCVAX) using less dosage Chemo in conjunction with DCVAX-L. This is what you mentioned long time ago in your analysis. The current SOC using huge dose of Chemo may not be the most perfect approach. We might get even more than reported 12-13% survival rate if we use less Chemo with DCVAX-L.
We are learning new things everyday here in a good way.
Thanks, Flipper. I'm still somewhat confused about the trial with its result reported in graph form because it doesn't seem to conform to the trial protocol as described in clinicaltrial.gov. It was either changed considerably (see my reply to Lefty) or else the link that was given by skylimit was wrong